Skip to content

Efficacy and safety evaluation study of Amritbindu Siddha Tailam for use as a rejuvenating oil on face in healthy human adults

Efficacy and Safety Evaluation study of Amritbindu siddha tailum (Ayurvedic Oil Serum) for use a rejuvenating facial massage in healthy human adults

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/04/005698
Enrollment
26
Registered
2015-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Amritbindu Siddha Tailam: A poly herbal tailam recommended to apply 4-6 drops over face once daily for 8 days Control Intervention1: nil: nil

Sponsors

KVM Research Laboratories
Collaborator
KVM Research Laboratories
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy individuals between the age group of 15-55 years old, whose skin types are representative of all VI skin types as per the Fitzpatrik scale. Being mentally competent and able to understand all study requirements and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Subjects with severe liver, renal, cardiac or brain diseases. Pregnant or lactating women or women of childbearing potential whom are not practicing a reliable form of birth control (either with IUD or with stable usage of oral contraceptives). Unable to complete follow up. Allergic to any medication. With a history of alcohol and/or drug abuse.

Design outcomes

Primary

MeasureTime frame
To examine the effect of the test substance on the efficacy and tolerability of facial skinTimepoint: On day 04 and 08

Secondary

MeasureTime frame
To examine the influence of Amritbindu Ayurvediya Face Serum on sleeping pattern of the subject.Timepoint: On day 04 and 08

Countries

India

Contacts

Public ContactDr Venkateshwarlu K

Anasuya Ayurvedic Center

drvenkatesh64@gmail.com9945232107

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026